Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 112

Работа: Nanotechnology-based shikonin delivery strategies for modulating the tumor immune microenvironment efficacy

  1. Nano based drug delivery systems: recent developments and future prospects

    Jayanta Kumar Patra, Gitishree Das, Leonardo Fernandes Fraceto +9

    Обзорная статья2018Цитирований: 11
    ABI
  2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

    F. Stephen Hodi, Steven O’Day, David F. McDermott +26

    Статья2010Цитирований: 9
    ABI
  3. Natural products in drug discovery: advances and opportunities

    Atanas G. Atanasov, Sergey B. Zotchev, Verena M. Dirsch +71

    Обзорная статья2021Цитирований: 7
    ABI
  4. Engineering precision nanoparticles for drug delivery

    Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley +3

    Обзорная статья2020Цитирований: 5
    ABI
  5. Immunogenic cell death and DAMPs in cancer therapy

    Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek +3

    Обзорная статья2012Цитирований: 4
    ABI
  6. THE METABOLISM OF TUMORS IN THE BODY

    Otto Warbürg, Franz Wind, Erwin Negelein

    Статья1927Цитирований: 3
    ABI
  7. The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

    Alexandre Albanese, Peter S. Tang, Warren C. W. Chan

    Обзорная статья2012Цитирований: 3
    ABI
  8. Cisplatin in cancer therapy: Molecular mechanisms of action

    Shaloam Dasari, Paul Bernard Tchounwou

    Обзорная статья2014Цитирований: 3
    ABI
  9. Lactic acid polarizes macrophages to a tumor-promoting state

    Oscar R. Colegio

    Статья2015Цитирований: 2
    ABI
  10. Tumor glycolysis as a target for cancer therapy: progress and prospects

    Shanmugasundaram Ganapathy‐Kanniappan, Jean-François H. Geschwind

    Обзорная статья2013Цитирований: 2
    ABI
  11. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

    Kai Li, Houhui Shi, Benxia Zhang +6

    Обзорная статья2021Цитирований: 2
    ABI
  12. Next generation of immune checkpoint therapy in cancer: new developments and challenges

    Julian A. Marin‐Acevedo, Bhagirathbhai Dholaria, Aixa Soyano +3

    Обзорная статья2018Цитирований: 2
    ABI
  13. Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1

    Weibo Luo, Hongxia Hu, Ryan Chang +6

    Статья2011Цитирований: 2
    ABI
  14. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity

    Joy X. Wang, Stephen Yiu Chuen Choi, Xiaojia Niu +4

    Обзорная статья2020Цитирований: 2
    ABI
  15. Targeting the prostate tumor microenvironment by plant-derived natural products

    Jiacheng Wu, Hao Ji, Tiantian Li +7

    Статья2023Цитирований: 2
    ABI
  16. Tumor-Associated Macrophages: Implications in Cancer Immunotherapy

    Amy J. Petty, Yiping Yang

    Обзорная статья2017Цитирований: 2
    ABI
  17. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

    Matthew G. Vander Heiden, Lewis C. Cantley, Craig B. Thompson

    Обзорная статья2009Цитирований: 2
    ABI
  18. Gracillin Isolated from Reineckia carnea Induces Apoptosis of A549 Cells via the Mitochondrial Pathway

    Jianqiong Yang, Ling Cao, Yamei Li +6

    Статья2021Цитирований: 2
    ABI
  19. Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals

    János Szebeni

    Обзорная статья2014Цитирований: 2
    ABI